Media Library
icon
-
ImagelockLocations / ImageOutside meeting space on Novartis Campus BaselOne of many inspiring work environments on Novartis Campus Basel.
-
ImagelockLocations / ImageView of Fabrikstrasse 15, Novartis Campus Basel
-
ImagelockLocations / ImageView of Forum 1 and Fabrikstrasse, Novartis Campus Basel
-
VideolockCorporate Responsibility / B RollNovartis Animated Logo
-
VideolockManufacturing / B RollNIBR Cambridge, United states
-
VideolockManufacturing / B RollNIBR Basel
-
VideolockDisease Awareness / VideoManaging the TSC Transition to Adult CareAnn describes how to live with symptoms as an adult living with Tuberous Sclerosis Complex (TSC) .
-
ImagelockLeadership / ImageRob KowalskiChief People & Organization Officer since September 1, 2021│Member of the Executive Committee
-
PDFlockProducts / InfographicInterleukin 17-A (IL-17A) in PsoriasisA cornerstone cytokine (messenger protein) involved in the development of psoriasis and other autoimmune diseases.
-
PDFlockProducts / InfographicInterleukin 17-A (IL-17A) in Inflammatory Joint DiseaseIL-17A helps fight infection but in chronic inflammatory joint diseases, IL-17A is a key cytokine involved in disease development.
-
ImagelockProducts / ImageKymriah® (tisagenlecleucel) suspension for intravenous infusionPhoto of Kymriah™ (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019.
-
PDFlockProducts / Fact SheetRTH258 Brolucizumab Clinical TrialsNovartis brolucizumab (RTH258) demonstrates superiority versus aflibercept in key secondary endpoint measures of disease activity in nAMD, a leading cause of blindness.
Pagination
- ‹ Previous page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- …
- 26
- › Next page